- Home
- UZX vs DYAI Comparison
UZX vs DYAI Comparison
Compare UZX & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UZX | DYAI |
|---|---|---|
| Founded | 2011 | 1979 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.8M | 17.0M |
| IPO Year | 2023 | 2026 |
Fundamental Metrics
Financial Performance| Metric | UZX | DYAI |
|---|---|---|
| Price | $1.33 | $0.43 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 7.3M | 190.2K |
| Earning Date | 06-30-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,090,345.00 |
| Revenue This Year | N/A | $113.16 |
| Revenue Next Year | N/A | $94.92 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.07 | $0.34 |
| 52 Week High | $1.88 | $1.60 |
Technical Indicators
Market Signals| Indicator | UZX | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 66.07 | 36.11 |
| Support Level | $0.14 | $0.34 |
| Resistance Level | $1.88 | $0.87 |
| Average True Range (ATR) | 0.10 | 0.06 |
| MACD | 0.07 | 0.02 |
| Stochastic Oscillator | 69.03 | 62.48 |
Price Performance
Historical ComparisonAbout UZX Linkage Global Inc. Class A Ordinary Shares
Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.
About DYAI Dyadic International Inc.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.